DGAP-News: Alphaform AG: Provisional bankruptcy administrator appointed


DGAP-News: Alphaform AG / Key word(s): Insolvency
Alphaform AG: Provisional bankruptcy administrator appointed

29.07.2015 / 18:59

---------------------------------------------------------------------

Press release

Alphaform AG: Provisional bankruptcy administrator appointed

Feldkirchen, 29 July 2015. With its decision of 29 July 2015, Munich
District Court has appointed Dr. Hubert Ampferl of the law practice Dr.
Beck und Partner as the provisional bankruptcy administrator for Alphaform
AG. The company had applied for the opening of bankruptcy proceedings on 28
July 2015 on the grounds of impending insolvency.

The administrator will quickly garner an overview of Alphaform AG.
Over the course of the bankruptcy proceedings, the company intends,
together with the bankruptcy administrator, to continue to implement the
restructuring efforts in accordance with IDW S6, which were already begun
with in June 2015.

The operative business at Alphaform AG will continue as normal. Chairman of
the Board at Alphaform, Dr. Hanns-Dieter Aberle explained: "Alphaform has
stood for high-quality and punctual manufacturing for years now. The
current situation will not change this in any way whatsoever. Our customers
can continue to rely on us as they have always done.

About Alphaform 

Founded in 1996 and headquartered in Feldkirchen near Munich, Alphaform AG
is a leading European handler for the renovation of industrial development
and production with innovative 3D printing and rapid technologies. As a
service provider, Alphaform guides its clients from product development
through to product manufacture; it assists them in introducing and
utilising innovations and delivers expertise, engineering knowledge,
prototypes, individual parts, small-scale series, series and project
management.

Among others, Alphaform today serves the premium manufacturers of the
automotive industry, mechanical, plant and automotive engineering, the
aerospace industry, tool making and medical technology. Its particular
areas of expertise include complex assembly, lightweight construction and
orthopaedic implants and instruments. It has subsidiaries in Germany,
Finland, Sweden and the UK. Alphaform's shares are listed in the Prime
Standard segment of the Frankfurt stock exchange (code: ATF; securities
code number (WKN): 548 795).

Contact: 
Dr. Hanns-Dieter Aberle, CEO Thomas Kresser, CFO
Alphaform AG Alphaform AG
Kapellenstraße 10 Kapellenstraße 10
85622 Feldkirchen 85622 Feldkirchen
Tel.: +49 89 905002 35 Tel.: +49 89 905002 35
Fax: +49 89 905002 1035 Fax: +49 89 905002 1035
e-mail: hdaberle@alphaform.de  e-mail: tkresser@alphaform.de
Internet: www.alphaform.de Internet: www.alphaform.de

 

Disclaimer

This press release/ad-hoc disclosure is not an offer document and does not
constitute an offer of shares of Alphaform AG ("Company") nor an invitation
to an offer to buy or subscribe for shares or securities of the Company but
is provided for information only. This press release/ad-hoc disclosure may
contain forward-looking statements that are subject to risks and
uncertainties, including those pertaining to the anticipated benefits to be
realized from the proposals described herein. Forward-looking statements
may include, in particular, statements about future events, future
financial performance, plans, strategies, expectations, prospects,
competitive environment, regulation and supply and demand. The Company has
based these forward-looking statements on its views and assumptions with
respect to future events and financial performance. Actual financial
performance could differ materially from that projected in the
forward-looking statements due to the inherent uncertainty of estimates,
forecasts and projections, and financial performance may be better or worse
than anticipated. Given these uncertainties, persons should not put undue
reliance on any forward-looking statements. The information contained in
this presentation is subject to change without notice and the Company does
not undertake any duty to update the forward-looking statements, and the
estimates and assumptions associated with them, except to the extent
required by applicable laws and regulations.

Important notice to persons in the United States of America

All information in this press release/ad-hoc disclosure is being made
available in the United States of America only to persons believed by the
Company to be capable of understanding and evaluating the risks of a
transaction. No shares or other securities of the Company have been
registered or otherwise qualify for a public sale or resale under federal
or state laws in the United States of America. Each recipient of
information doing business in or organized under any federal or state laws
in the United States of America or in areas subject to its jurisdiction
represents that it is an "accredited investor" as defined by Rule 501 or
Regulation D under the Securities Act of 1993 ("the Act") and acknowledges
that none of the shares in the Company will be registered under the Act and
cannot be resold in the absence of such registration or the availability of
an exemption there from. The shares in the Company have not been approved
or disapproved by the United States Securities and Exchange Commission, any
state securities commission or other regulatory authority, nor have any of
these authorities passed judgment upon or endorsed the merits of an
investment in the shares of the Company or the accuracy or adequacy of this
presentation. Any representation to the contrary is a criminal offence.

Important notice to persons in the United Kingdom

All information in this press release/ad-hoc disclosure is being made
available to the recipients on the basis that they are persons covered by
Article 11(3) of the Financial Services Act 1986 (Investment
Advertisements) (Exemptions) Order 1996. By accepting this document the
recipient warrants and represents that he or it is such a person.



---------------------------------------------------------------------

29.07.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                                    
Company:     Alphaform AG                                               
             Kapellenstraße 10                                          
             85622 Feldkirchen                                          
             Germany                                                    
Phone:       +49 (0)89 905002 - 0                                       
Fax:         +49 (0)89 905002 - 90                                      
E-mail:      ir@alphaform.de                                            
Internet:    www.alphaform.de                                           
ISIN:        DE0005487953                                               
WKN:         548795                                                     
Listed:      Regulated Market in Frankfurt (Prime Standard); Regulated  
             Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,  
             Stuttgart                                                  
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
382103 29.07.2015